breast cancer

Abstract: Pathway to Cure is a multimodal eHealth platform for oncology care providers and patients developed by a multidisciplinary team at the University of Nebraska Medical Center’s Fred & Pamela Buffett...

...

09/18/2020

Journal of Clinical Pathways

Interview

Current Therapies and Future Options for Breast Cancer Treatment: An Interview With Yolanda Bryce, MD

03/25/2020

Dr Bryce spoke with IO Learning about current breast cancer treatments and future options for the 1 in 8 women who will ultimately face breast cancer in their lifetime.  What contributes to your ability to treat breast cancer...

Dr Bryce spoke with IO Learning...

03/25/2020

IO Learning

News

Can Trapezius Ports be Used as an Alternative Site to Chest Ports?

12/16/2018

A new study found the long-term results of and patient satisfaction with trapezius ports in breast cancer patients is associated with high overall patient satisfaction, providing a safe and feasible alternative site to chest ports. The...

A new study found the long-term...

12/16/2018

IO Learning

News

Can Genomic Profiling Predict Radioembolization Outcomes in Patients with Metastatic Breast Cancer?

08/25/2018

A recent study found that PI3K pathway mutations in patients with metastatic breast cancer are associated with early imaging response after radioembolization, which is associated with prolonged survival. The results were published in the...

A recent study found that PI3K...

08/25/2018

IO Learning

News

Is Stereotactic Radiofrequency Ablation a Safe Option for Treating Breast Cancer Metastases?

01/02/2018

In some patients with breast cancer liver metastases, surgical liver resection is not an option, but stereotactic radiofrequency ablation can be offered as a safe and minimally invasive alternative. Researchers reported their findings in the...

In some patients with breast...

01/02/2018

IO Learning

Research in Review

Understanding the Role of Prolactin Receptor in Triple Negative Breast Cancer

10/28/2016

JCP Editors

Screening breast cancer patients for the prolactin receptor could improve the prognosis for patients and help avoid unnecessary and invasive treatments, according to new research that examined the prognostic and...

...

10/28/2016

Journal of Clinical Pathways